Parametric Portfolio Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $228M | Buy |
326,954
+26,077
| +9% | +$18.2M | 0.12% | 153 |
|
|
2021
Q4 | $190M | Buy |
300,877
+14,185
| +5% | +$8.96M | 0.1% | 187 |
|
|
2021
Q3 | $174M | Buy |
286,692
+32,922
| +13% | +$19.9M | 0.1% | 192 |
|
|
2021
Q2 | $142M | Buy |
253,770
+13,514
| +6% | +$7.55M | 0.08% | 237 |
|
|
2021
Q1 | $114M | Sell |
240,256
-18,215
| -7% | -$8.62M | 0.07% | 284 |
|
|
2020
Q4 | $125M | Sell |
258,471
-235
| -0.1% | -$114K | 0.08% | 226 |
|
|
2020
Q3 | $145M | Buy |
258,706
+16,268
| +7% | +$9.11M | 0.1% | 170 |
|
|
2020
Q2 | $151M | Buy |
242,438
+21,141
| +10% | +$13.2M | 0.12% | 151 |
|
|
2020
Q1 | $108M | Buy |
221,297
+51,064
| +30% | +$24.9M | 0.1% | 184 |
|
|
2019
Q4 | $63.9M | Sell |
170,233
-1,125
| -0.7% | -$422K | 0.05% | 359 |
|
|
2019
Q3 | $47.5M | Sell |
171,358
-16,103
| -9% | -$4.47M | 0.04% | 444 |
|
|
2019
Q2 | $58.7M | Sell |
187,461
-60,403
| -24% | -$18.9M | 0.05% | 365 |
|
|
2019
Q1 | $102M | Buy |
247,864
+10,217
| +4% | +$4.2M | 0.09% | 220 |
|
|
2018
Q4 | $88.8M | Buy |
237,647
+24,766
| +12% | +$9.25M | 0.09% | 219 |
|
|
2018
Q3 | $86M | Buy |
212,881
+44,406
| +26% | +$17.9M | 0.08% | 251 |
|
|
2018
Q2 | $58.1M | Sell |
168,475
-9,985
| -6% | -$3.44M | 0.06% | 329 |
|
|
2018
Q1 | $61.5M | Sell |
178,460
-8,175
| -4% | -$2.82M | 0.06% | 303 |
|
|
2017
Q4 | $70.2M | Buy |
186,635
+19,823
| +12% | +$7.45M | 0.07% | 276 |
|
|
2017
Q3 | $74.6M | Buy |
166,812
+19,729
| +13% | +$8.82M | 0.08% | 247 |
|
|
2017
Q2 | $72.2M | Buy |
147,083
+18,894
| +15% | +$9.28M | 0.09% | 226 |
|
|
2017
Q1 | $49.7M | Sell |
128,189
-7,453
| -5% | -$2.89M | 0.08% | 239 |
|
|
2016
Q4 | $49.8M | Sell |
135,642
-61,126
| -31% | -$22.4M | 0.07% | 284 |
|
|
2016
Q3 | $79.1M | Buy |
196,768
+45,919
| +30% | +$18.5M | 0.12% | 181 |
|
|
2016
Q2 | $52.7M | Buy |
150,849
+46,952
| +45% | +$16.4M | 0.08% | 237 |
|
|
2016
Q1 | $37.4M | Buy |
103,897
+9,889
| +11% | +$3.56M | 0.06% | 318 |
|
|
2015
Q4 | $51M | Buy |
94,008
+14,466
| +18% | +$7.85M | 0.09% | 232 |
|
|
2015
Q3 | $37M | Buy |
79,542
+3,848
| +5% | +$1.79M | 0.07% | 294 |
|
|
2015
Q2 | $38.6M | Sell |
75,694
-5,156
| -6% | -$2.63M | 0.08% | 258 |
|
|
2015
Q1 | $36.5M | Buy |
80,850
+4,398
| +6% | +$1.99M | 0.07% | 279 |
|
|
2014
Q4 | $31.4M | Sell |
76,452
-165
| -0.2% | -$67.7K | 0.07% | 309 |
|
|
2014
Q3 | $27.6M | Buy |
76,617
+2,534
| +3% | +$914K | 0.06% | 326 |
|
|
2014
Q2 | $20.9M | Buy |
74,083
+5,351
| +8% | +$1.51M | 0.05% | 430 |
|
|
2014
Q1 | $20.6M | Buy |
68,732
+10,041
| +17% | +$3.02M | 0.05% | 423 |
|
|
2013
Q4 | $16.2M | Buy |
58,691
+1,638
| +3% | +$451K | 0.04% | 494 |
|
|
2013
Q3 | $17.9M | Buy |
57,053
+5,209
| +10% | +$1.63M | 0.05% | 427 |
|
|
2013
Q2 | $11.7M | Buy |
+51,844
| New | +$11.7M | 0.03% | 553 |
|